News
News Releases
In-Vivo Science and Axcelead DDP Entered into Cooperative Agreement for Drug Discovery Services Using Disease Model Animals
In-Vivo Science, Inc. (Headquarters: Meguro-ku, Tokyo; Branch Office: Kawasaki City, Kanagawa Prefecture; President: Koji Yoshimura; hereinafter “In-Vivo...
Results of joint research with the University of Tokyo published in the international scientific journal “Nature Communications”
Axcelead Drug Discovery Partners Inc. (Headquarters: Fujisawa City, Kanagawa Prefecture; President & CEO: Nobuhiko Yamada; hereinafter “Axcelead...
FRONTEO and Axcelead DDP Sign Master Collaboration Agreement for AI Drug Discovery Support Partnership
FRONTEO Inc. (Headquarters: Minato-ku, Tokyo; President & CEO: Masahiro Morimoto; hereinafter “FRONTEO”) and Axcelead Drug Discovery Partners...
Axcelead DDP’s Drug Discovery Support Business Honored with the 6th Japan Medical Research and Development Grand Prize
Axcelead Drug Discovery Partners Inc. (“Axcelead DDP”) is pleased to announce that it has been honored with...
Discussions Begin on Collaborative Genomic Drug Discovery Support Using the IQVIA Genome Wide Study Platform
Axcelead Drug Discovery Partners Inc. (Headquarters: Fujisawa, Kanagawa; President and CEO: Nobuhiko Yamada; hereinafter, “Axcelead DDP”) and...